Healthcare Archives - The Wire China

China’s gene research industry faces scrutiny after recent scandals, but a sanctioned BGI holds on to its top spot.

China’s tech giants are betting that weight management could become a new growth opportunity for their healthcare businesses.

U.S. supply chains with connections to Xinjiang and the Chinese military are heavily regulated — just not for pharmaceuticals.

Despite regulatory obstacles, big pharma is so confident in China’s R&D they’re purchasing the rights to medicines that don’t yet exist.

Led by one-half of China’s pharma power couple, Jiangsu Hengrui Medicine Company is attracting international attention with its innovative drugs.

Can artificial intelligence fix China’s fragmented public healthcare system?

At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked...

The medic and writer discusses China's success in harnessing technology into healthcare and the pervasive issue of inequality across the system.

Both the U.S. and China have held off on tariffing each other’s pharmaceuticals.

A surge in dealmaking that's helped Chinese biotech and healthcare firms sell their products globally faces several headwinds.

Big tech companies see an opportunity in healthcare but making their businesses profitable has been a challenge to date.

Deep linkages exist between forced labor in Xinjiang and the global pharmaceutical supply chain, according to a new report.